Nanoscale Cryonics Presales Normalize Risk

Startups are offering direct‑to‑consumer pre‑sales for high‑risk biological preservation (e.g., Nectome's $100k presale claiming room‑temperature nanoscale brain preservation). Selling speculative life‑extension services publicly both normalizes extreme biotech entrepreneurship and forces faster ethical and regulatory pressure points around funerary practices, informed consent, and long‑term custody of preserved material. — If commercial presales of speculative preservation become common, they will push regulators, ethicists, and the public to confront governance, consumer‑protection, and scientific‑verification questions sooner than they might otherwise.